Increased activation of the phosphatidyl-inositol-3 kinase/AKT and NFkB pathways have both been identified as critical pathways in cancer initiation and progression in a variety of human malignancies, including prostate cancer. This evidence concerns the gene NFKB1 and Familial prostate cancer.